Category: Wearables
-
Respiree raises $11.6 million to expand AI health monitoring globally
Singapore-based Respiree plans to use the funding to scale its AI platform for detecting patient deterioration.
-
WearOptimo’s AI-powered sensor detects mild dehydration
The company’s CEO and founder talks about clinical accuracy, development, and the launch of the AI-powered wearable sensor.
-
Dexcom shares plunge following FDA warning letter
The company noted that it does not expect a ‘material impact’ from the US FDA warning letter on its manufacturing capacity or its 2025 revenue guidance.
Latest posts
-
Navigating the Risks and Rewards of Biomarker-Based Surrogates and Accelerated Approval
The risks and rewards of biomarker-based surrogates are crucial for optimizing clinical trial outcomes and guiding effective treatments.
-
ASH25: Gallop’s LYT-200 shows unprecedented survival in AML
The company’s execs talk about the striking efficacy and safety signals seen in Phase I data, the science behind the molecule, and their vision for transforming AML therapy.
-
Promis reports first human evidence of aβ oligomer reduction by pmn310
PMN310 demonstrates dose-dependent reduction of amyloid-beta oligomers in human CSF, marking a key milestone in Alzheimer’s treatment development.
-
Urologic Health secures $11 million for non-invasive bladder monitoring
Urologic Health raises $11million seed funding to advance a catheter-free bladder monitoring platform toward FDA clearance and US market entry.
-
Novo Nordisk’s denecimig cuts bleeding in hemophilia A regardless of inhibitors
Phase III trial shows once‑monthly and once‑weekly denecimig (Mim8) significantly reduces annualized bleeding rate versus standard care, with up to 95% of patients bleed‑free.